Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2025-12-24 @ 2:52 PM
NCT ID: NCT01713959
Eligibility Criteria: Inclusion Criteria: * Male and female, ages 18-75 * Subject is in good health * Diagnosis of bilateral axillary hyperhidrosis refractory to previous topical therapies * At least 50 mg of spontaneous resting axillary sweat production in each axilla measured gravimetrically at room temperature/humidity (20 - 25.6°C/20-80%) over a period of 5 minutes. (Patients should be at rest for at least 30 minutes after physical exercise including walking.) * HDSS score of 3 or 4. * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period. Exclusion Criteria: * Dermal disorder including infection at anticipated treatment sites in either axilla. * Previous botulinum toxin treatment of the axilla in the past year. * Expected use of botulinum toxin for the treatment of any other disease during the study period. * Known allergy to starch powder or iodine. * Secondary hyperhidrosis, for example, hyperhidrosis that is secondary to other underlying diseases including hyperthyroidism, lymphoma and malaria. * Previous surgical treatment of hyperhidrosis including sympathectomy, surgical debulking of the sweat glands, subcutaneous tissue curettage and ultrasonic surgery. * Women who are pregnant, lactating, possibly pregnant or planning a pregnancy during the study period.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 75 Years
Study: NCT01713959
Study Brief:
Protocol Section: NCT01713959